Gedeptin is a non-replicating adenoviral vector delivering the E. coli purine nucleoside phosphorylase (PNP) gene directly into tumor tissue. Following intratumoral injection, patients receive ...
Interim data from Wave Life Sciences' INLIGHT trial showed promising results for WVE-007, an investigational treatment for obesity.
The poster presentation, titled “COMBAT-ALS Phase 2b/3 Trial of MN-166 (Ibudilast) in ALS: Trial Update and Basic Characteristics” (Reference # CTL-21), highlighted the following: Overview of the ...
Summary • HCW Biologics Inc. (HCWB) shares surged 22.73% in after-hours trading to $2.43 following a clinical trial update.• ...
TipRanks on MSN
Candel Therapeutics hosts virtual R&D day on immunotherapy
An announcement from Candel Therapeutics ( ($CADL) ) is now available. On December 5, 2025, Candel Therapeutics will host a virtual R&D Day to ...
An update from CSPC Pharmaceutical Group ( ($HK:1093) ) is now available. CSPC Pharmaceutical Group Limited has announced that its GLP-1/GIP ...
Digit health technologies (DHT) are a key aspect of U.S. Health & Human Services (HHS) Secretary Robert F. Kennedy Jr.’s Make America Healthy ...
Microsoft faces intensifying competition from Alphabet/Google, as both companies' AI and cloud strategies increasingly ...
Belém, 11 November 2025: The World Business Council for Sustainable Development (WBCSD) and One Planet Network (hosted by UNEP) have announced the official launch of the Global Circularity Protocol ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback